×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Aclaris Therapeutics Inc. (ACRS) NASDAQ

$1.24 (0.02) (-1.59%)

Market Cap: $89.37M

As of 03/28/24 04:00 PM EDT. Market closed.

(ACRS)

Aclaris Therapeutics Inc. (ACRS)
NASDAQ

$1.24
(0.02) (-1.59%)

Market Cap: $89.37M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

aclaris therapeutics, inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. aclaris is focused on market segments with no fda-approved medications or where treatment gaps exist. aclaris was founded by dermatologists and is led ... read more

aclaris therapeutics, inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. aclaris is focused on market segments with no fda-approved medications or where treatment gaps exist. aclaris was founded by dermatologists and is led by a team with extensive experience in developing and commercializing dermatologic treatments. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Neal Walker
Full Time Employees
62
CEO Compensation (Base)
$550,000
CEO Compensation (Total)
$4.36M
URL
Address
640 Lee Rd Ste 200, Pennsylvania, Wayne, 19087-5636.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Neal Walker
Full Time Employees
62
CEO Compensation (Base)
$550,000
CEO Compensation (Total)
$4.36M
Address
640 Lee Rd Ste 200, Pennsylvania, Wayne, 19087-5636.
PRICE CHART FOR ACLARIS THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.27
Previous Close
$1.26
Days Range
$1.19 - $1.29
52 week range
$0.59 - $11.12
Volume
599,308
Avg. Volume (30 days)
1,264,550
Market Cap
$89.37M
Dividend Yield
-
P/E
(1.01)
Shares Outstanding
70,925,042
Open
$1.27
Previous Close
$1.26
Days Range
$1.19 - $1.29
52 week range
$0.59 - $11.12
Volume
599,308
Avg. Volume (30 days)
1,264,550
Market Cap
$89.37M
Dividend Yield
-
P/E
(1.01)
Shares Outstanding
70,925,042
FINANCIAL STATEMENTS FOR ACLARIS THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ACLARIS THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Walker NealInterim President and CEOMar 01, 2024 Option Exercise$1.243,2233,9971,279,445Mar 05, 2024, 05:08 PM
Monahan JosephChief Scientific OfficerMar 02, 2024 Option Exercise$1.243,5314,378186,783Mar 05, 2024, 05:04 PM
Monahan JosephChief Scientific OfficerMar 01, 2024 Option Exercise$1.2417,75222,012177,814Mar 05, 2024, 05:04 PM
Balthaser KevinChief Financial OfficerMar 02, 2024 Option Exercise$1.2442752923,983Mar 05, 2024, 05:02 PM
Balthaser KevinChief Financial OfficerMar 01, 2024 Option Exercise$1.249901,22822,910Mar 05, 2024, 05:02 PM
Monahan JosephChief Scientific OfficerFeb 01, 2024 Option Exercise$1.202,5833,100134,641Feb 05, 2024, 07:31 PM
Loerop JamesChief Business OfficerFeb 01, 2024 Option Exercise$1.206,4217,70534,017Feb 05, 2024, 07:29 PM
Manion Douglas J.Pres and CEOJan 01, 2024 Option Exercise$1.059,1259,58141,813Jan 03, 2024, 04:44 PM
Monahan JosephChief Scientific OfficerOct 23, 2023 Sale$5.086,00030,460129,724Oct 25, 2023, 04:28 PM
Balthaser KevinChief Financial OfficerSep 06, 2023 Buy$7.909,49074,97115,461Sep 07, 2023, 04:16 PM
Balthaser KevinChief Financial OfficerSep 01, 2023 Option Exercise$7.902852,2525,971Sep 05, 2023, 05:08 PM
Loerop JamesChief Business OfficerAug 28, 2023 Buy$6.8014,70599,95921,688Aug 28, 2023, 04:39 PM
Monahan JosephChief Scientific OfficerAug 21, 2023 Sale$7.326,00043,895135,724Aug 22, 2023, 04:31 PM
Manion Douglas J.Pres and CEOAug 01, 2023 Option Exercise$9.814,43743,52723,938Aug 03, 2023, 04:24 PM
Molineaux Christopher P.DirectorJun 20, 2023 Option Exercise$1.4116,50023,26548,503Jun 22, 2023, 04:32 PM
Monahan JosephChief Scientific OfficerJun 20, 2023 Sale$10.286,00061,663141,724Jun 22, 2023, 04:30 PM
Molineaux Christopher P.DirectorJun 15, 2023 Option Exercise$1.3624933832,003Jun 20, 2023, 04:31 PM
Manion Douglas J.Pres and CEOMar 17, 2023 Buy$7.866,30049,53212,800Mar 17, 2023, 05:03 PM
Manion Douglas J.Pres and CEOMar 09, 2023 Buy$7.746,50050,2786,500Mar 09, 2023, 05:56 PM
Walker NealDirectorMar 03, 2023 Sale$12.6330,240382,0701,273,202Mar 03, 2023, 08:37 PM
Walker NealDirectorMar 02, 2023 Sale$12.3729,000358,5881,285,188Mar 03, 2023, 08:37 PM
Monahan JosephChief Scientific OfficerMar 03, 2023 Sale$12.6316,037202,615147,724Mar 03, 2023, 08:12 PM
Monahan JosephChief Scientific OfficerMar 02, 2023 Sale$12.3714,800183,024151,261Mar 03, 2023, 08:12 PM
Balthaser KevinChief Financial OfficerMar 03, 2023 Sale$12.6389411,2905,256Mar 03, 2023, 08:09 PM
Balthaser KevinChief Financial OfficerMar 02, 2023 Sale$12.291,00012,2894,650Mar 03, 2023, 08:09 PM
Monahan JosephChief Scientific OfficerFeb 15, 2023 Sale$13.065,00065,31191,386Feb 17, 2023, 04:34 PM
Loerop JamesChief Business OfficerFeb 08, 2023 Sale$13.894,26759,2726,983Feb 10, 2023, 04:55 PM
Walker NealDirectorFeb 02, 2023 Sale$16.255,00081,2481,179,684Feb 03, 2023, 05:09 PM
Walker NealDirectorFeb 01, 2023 Sale$16.7525,000418,6751,180,763Feb 03, 2023, 05:09 PM
Walker NealDirectorJan 04, 2023 Sale$14.8915,000223,3421,205,763Jan 04, 2023, 06:20 PM
Walker NealDirectorJan 03, 2023 Sale$15.2525,000381,2131,222,381Jan 04, 2023, 06:20 PM
Monahan JosephChief Scientific OfficerDec 15, 2022 Sale$15.885,00079,41296,386Dec 16, 2022, 04:57 PM
SCHIFF ANDREW NDirectorNov 14, 2022 Sale$17.081,37123,417434,455Nov 14, 2022, 04:51 PM
SCHIFF ANDREW NDirectorNov 11, 2022 Sale$17.0641,160702,177435,826Nov 14, 2022, 04:51 PM
SCHIFF ANDREW NDirectorNov 10, 2022 Sale$17.0211,395193,995476,986Nov 14, 2022, 04:51 PM
SCHIFF ANDREW NDirectorOct 26, 2022 Sale$17.0014,540247,253488,381Oct 26, 2022, 07:09 PM
SCHIFF ANDREW NDirectorOct 25, 2022 Sale$17.0212,018204,516502,921Oct 26, 2022, 07:09 PM
SCHIFF ANDREW NDirectorOct 24, 2022 Sale$17.0114,616248,586514,939Oct 26, 2022, 07:09 PM
SCHIFF ANDREW NDirectorOct 17, 2022 Sale$16.0519,944320,087561,648Oct 19, 2022, 04:49 PM
SCHIFF ANDREW NDirectorOct 18, 2022 Sale$16.8932,093542,022529,555Oct 19, 2022, 04:49 PM
Monahan JosephChief Scientific OfficerOct 17, 2022 Sale$15.985,00079,907101,386Oct 19, 2022, 04:45 PM
SCHIFF ANDREW NDirectorOct 07, 2022 Sale$16.167,324118,349581,592Oct 11, 2022, 04:35 PM
SCHIFF ANDREW NDirectorOct 06, 2022 Sale$16.5437,839625,744588,916Oct 06, 2022, 05:58 PM
SCHIFF ANDREW NDirectorOct 04, 2022 Sale$16.017,700123,259626,755Oct 06, 2022, 05:58 PM
SCHIFF ANDREW NDirectorJun 17, 2022 Sale$15.1419,565296,2690Jun 21, 2022, 04:57 PM
Walker NealPresident and CEOApr 25, 2022 Sale$15.1820,000303,6561,245,763Apr 25, 2022, 05:13 PM
Walker NealPresident and CEOApr 22, 2022 Sale$15.0425,000376,0971,265,763Apr 25, 2022, 05:13 PM
Walker NealPresident and CEOApr 21, 2022 Sale$15.2425,000380,9471,290,763Apr 25, 2022, 05:13 PM
Monahan JosephChief Scientific OfficerApr 18, 2022 Sale$16.2830,000488,298106,386Apr 20, 2022, 05:06 PM
Walker NealPresident and CEOMar 11, 2022 Sale$15.9156,303896,0451,315,763Mar 14, 2022, 04:58 PM
Ruffo FrankChief Financial OfficerMar 10, 2022 Sale$15.5512,823199,335201,883Mar 14, 2022, 04:56 PM
Monahan JosephChief Scientific OfficerMar 10, 2022 Sale$15.7127,165426,803136,386Mar 14, 2022, 04:53 PM
Monahan JosephChief Scientific OfficerFeb 09, 2022 Sale$12.683834,85787,301Feb 11, 2022, 04:22 PM
Ruffo FrankChief Financial OfficerFeb 09, 2022 Sale$12.661,38817,568172,359Feb 11, 2022, 04:18 PM
Walker NealPresident and CEOFeb 09, 2022 Sale$12.663,59545,5131,239,387Feb 11, 2022, 04:15 PM
Monahan JosephChief Scientific OfficerSep 01, 2021 Option Exercise$17.221,04117,92686,634Sep 02, 2021, 05:39 PM
Gordon David N.Chief Medical OfficerJul 13, 2021 Sale$16.982,63144,675147,447Jul 14, 2021, 05:32 PM
Ali-Jackson KamilChief Legal OfficerJun 03, 2021 Sale$21.969,492208,421122,196Jun 04, 2021, 07:52 PM
Gordon David N.Chief Medical OfficerJun 02, 2021 Sale$21.6337,914820,209150,878Jun 02, 2021, 09:49 PM
Gordon David N.Chief Medical OfficerJun 01, 2021 Sale$23.0114,000322,165186,877Jun 02, 2021, 09:49 PM
Ali-Jackson KamilChief Legal OfficerJun 02, 2021 Sale$21.6430,119651,664149,324Jun 02, 2021, 09:47 PM
Ali-Jackson KamilChief Legal OfficerJun 01, 2021 Sale$23.0215,000345,299167,061Jun 02, 2021, 09:47 PM
Monahan JosephChief Scientific OfficerJun 02, 2021 Sale$21.6421,790471,43788,892Jun 02, 2021, 09:45 PM
Ruffo FrankChief Financial OfficerJun 02, 2021 Sale$21.6415,037325,383172,322Jun 02, 2021, 09:43 PM
Walker NealPresident and CEOJun 02, 2021 Sale$21.6433,260719,7351,237,699Jun 02, 2021, 09:41 PM
Ruffo FrankChief Financial OfficerApr 26, 2021 Sale$25.8027,339705,228151,820Apr 26, 2021, 09:45 PM
Ruffo FrankChief Financial OfficerApr 23, 2021 Sale$26.6630,000799,660179,859Apr 26, 2021, 09:45 PM
Ruffo FrankChief Financial OfficerApr 22, 2021 Sale$26.8430,000805,218209,059Apr 26, 2021, 09:45 PM
Walker NealPresident and CEOApr 22, 2021 Sale$26.8430,000805,2391,192,427Apr 26, 2021, 09:43 PM
Gordon David N.Chief Medical OfficerMar 02, 2021 Option Exercise$23.252,28053,010108,492Mar 03, 2021, 08:42 PM
Gordon David N.Chief Medical OfficerMar 01, 2021 Option Exercise$24.065,660136,180102,475Mar 03, 2021, 08:42 PM
Ali-Jackson KamilChief Legal OfficerMar 02, 2021 Option Exercise$23.251,90644,315143,618Mar 03, 2021, 08:39 PM
Ali-Jackson KamilChief Legal OfficerMar 01, 2021 Option Exercise$24.064,934118,712138,887Mar 03, 2021, 08:39 PM
Ruffo FrankChief Financial OfficerMar 02, 2021 Option Exercise$23.252,84466,123239,059Mar 03, 2021, 08:36 PM
Ruffo FrankChief Financial OfficerMar 01, 2021 Option Exercise$24.067,333176,432233,606Mar 03, 2021, 08:36 PM
Walker NealPresident and CEOMar 02, 2021 Option Exercise$23.257,982185,5821,222,427Mar 03, 2021, 08:32 PM
Walker NealPresident and CEOMar 01, 2021 Option Exercise$24.0639,792957,3951,212,156Mar 03, 2021, 08:32 PM
Mehra AnandDirectorFeb 02, 2021 Option Exercise$18.3414,632268,29830,841Feb 03, 2021, 05:33 PM
Ruffo FrankChief Financial OfficerFeb 01, 2021 Option Exercise$21.351,30827,926215,189Feb 03, 2021, 05:29 PM
Ali-Jackson KamilChief Legal OfficerFeb 01, 2021 Option Exercise$21.351,31828,139126,646Feb 03, 2021, 05:26 PM
Walker NealPresident and CEOFeb 01, 2021 Option Exercise$21.353,31670,7971,155,798Feb 03, 2021, 05:23 PM
Walker NealPresident and CEODec 15, 2020 Option Exercise$4.598713,9981,148,314Dec 17, 2020, 05:08 PM
Ruffo FrankChief Financial OfficerDec 15, 2020 Option Exercise$4.593701,698212,622Dec 17, 2020, 05:07 PM
Ali-Jackson KamilChief Legal OfficerDec 15, 2020 Option Exercise$4.594982,286124,089Dec 17, 2020, 05:06 PM
Walker NealPresident and CEOSep 01, 2020 Option Exercise$2.3323,87255,6221,146,151Sep 03, 2020, 04:23 PM
Gordon David N.Chief Medical OfficerJul 02, 2020 Option Exercise$1.501,3602,04087,535Jul 07, 2020, 07:25 PM
Walker NealPresident and CEOJun 01, 2020 Option Exercise$1.3220,97627,6881,086,931Jun 03, 2020, 04:47 PM
Ruffo FrankChief Financial OfficerJun 01, 2020 Option Exercise$1.329,45112,475211,692Jun 03, 2020, 04:45 PM
Gordon David N.Chief Medical OfficerJun 01, 2020 Option Exercise$1.3224,04531,73982,895Jun 03, 2020, 04:43 PM
Ali-Jackson KamilChief Legal OfficerJun 01, 2020 Option Exercise$1.329,53412,585122,853Jun 03, 2020, 04:42 PM
Walker NealPresident and CEOMar 02, 2020 Option Exercise$1.2642,72453,8321,034,893Mar 04, 2020, 04:30 PM
Ruffo FrankChief Financial OfficerMar 02, 2020 Option Exercise$1.267,1629,024187,955Mar 04, 2020, 04:30 PM
Ali-Jackson KamilChief Legal OfficerMar 02, 2020 Option Exercise$1.264,7796,02299,199Mar 04, 2020, 04:22 PM
Gordon David N.Chief Medical OfficerMar 02, 2020 Option Exercise$1.265,5126,94519,440Mar 04, 2020, 04:20 PM
Walker NealPresident and CEOFeb 03, 2020 Option Exercise$1.283,6754,704928,903Feb 04, 2020, 07:13 PM
Ruffo FrankChief Financial OfficerFeb 03, 2020 Option Exercise$1.281,3081,674169,367Feb 04, 2020, 07:12 PM
Ali-Jackson KamilChief Legal OfficerFeb 03, 2020 Option Exercise$1.281,3181,68786,803Feb 04, 2020, 07:11 PM
Walker NealPresident and CEODec 18, 2019 Option Exercise$1.817431,345921,778Dec 20, 2019, 04:19 PM
Ruffo FrankChief Financial OfficerDec 18, 2019 Option Exercise$1.81356644166,800Dec 20, 2019, 04:18 PM
Ali-Jackson KamilChief Legal OfficerDec 18, 2019 Option Exercise$1.8127750184,246Dec 20, 2019, 04:17 PM
Walker NealPresident and CEODec 16, 2019 Option Exercise$1.807821,408919,596Dec 18, 2019, 11:04 AM
Ruffo FrankChief Financial OfficerDec 16, 2019 Option Exercise$1.80370666165,906Dec 18, 2019, 11:02 AM
Ali-Jackson KamilChief Legal OfficerDec 16, 2019 Option Exercise$1.8049789583,448Dec 18, 2019, 11:00 AM
Gordon David N.Chief Medical OfficerJul 02, 2019 Option Exercise$2.341,6483,8564,352Jul 03, 2019, 04:44 PM
Flynn James E10% OwnerJun 27, 2019 Sale$2.69590,8011,589,6683,159,165Jul 01, 2019, 05:01 PM
Flynn James E10% OwnerJun 27, 2019 Sale$2.69108,674292,409964,101Jul 01, 2019, 05:01 PM
Flynn James E10% OwnerJun 26, 2019 Sale$4.501,3526,0863,749,966Jun 26, 2019, 05:52 PM
Flynn James E10% OwnerJun 26, 2019 Sale$4.503521,5851,072,775Jun 26, 2019, 05:52 PM
Flynn James E10% OwnerJun 24, 2019 Sale$4.5250,177226,9253,792,168Jun 25, 2019, 06:31 PM
Flynn James E10% OwnerJun 24, 2019 Sale$4.5213,06359,0771,083,761Jun 25, 2019, 06:31 PM
Flynn James E10% OwnerJun 21, 2019 Sale$4.62269,4021,243,3983,842,345Jun 25, 2019, 06:31 PM
Flynn James E10% OwnerJun 21, 2019 Sale$4.6270,135323,7011,096,824Jun 25, 2019, 06:31 PM
Flynn James E10% OwnerJun 25, 2019 Sale$4.5140,850184,1893,751,318Jun 25, 2019, 06:31 PM
Flynn James E10% OwnerJun 25, 2019 Sale$4.5110,63447,9481,073,127Jun 25, 2019, 06:31 PM
Flynn James E10% OwnerMay 09, 2019 Sale$6.16172,8001,064,0161,238,828May 13, 2019, 05:24 PM
Flynn James E10% OwnerMay 09, 2019 Sale$6.16261,3451,609,2324,220,443May 13, 2019, 05:24 PM
Flynn James E10% OwnerMay 10, 2019 Sale$6.0571,869434,7501,166,959May 13, 2019, 05:24 PM
Flynn James E10% OwnerMay 10, 2019 Sale$6.05108,696657,5244,111,747May 13, 2019, 05:24 PM
Walker NealPresident and CEOFeb 01, 2019 Option Exercise$6.963,57924,910917,345Feb 05, 2019, 06:34 PM
Powala ChristopherChief Reg & Develop OfficerFeb 01, 2019 Option Exercise$6.961,1147,753141,729Feb 05, 2019, 06:33 PM
Shanler StuartChief Scientific OfficerFeb 01, 2019 Option Exercise$6.961,3089,104272,047Feb 05, 2019, 06:32 PM
Ruffo FrankChief Financial OfficerFeb 01, 2019 Option Exercise$6.961,3089,104164,976Feb 05, 2019, 06:31 PM
Fair BrettChief Commercial OfficerFeb 01, 2019 Option Exercise$6.961,3089,10410,582Feb 05, 2019, 06:30 PM
Ali-Jackson KamilChief Legal OfficerFeb 01, 2019 Option Exercise$6.961,3089,10482,212Feb 05, 2019, 06:29 PM
Ruffo FrankChief Financial OfficerDec 18, 2018 Option Exercise$6.303562,243162,409Dec 21, 2018, 07:34 AM
Walker NealPresident and CEODec 18, 2018 Option Exercise$6.308335,248910,124Dec 21, 2018, 07:33 AM
Shanler StuartChief Scientific OfficerDec 18, 2018 Option Exercise$6.304122,596269,480Dec 21, 2018, 07:32 AM
Fair BrettChief Commercial OfficerDec 18, 2018 Option Exercise$6.304983,1378,015Dec 21, 2018, 07:31 AM
Powala ChristopherChief Reg & Develop OfficerDec 18, 2018 Option Exercise$6.304462,810139,443Dec 21, 2018, 07:29 AM
Ali-Jackson KamilChief Legal OfficerDec 18, 2018 Option Exercise$6.303061,92879,645Dec 20, 2018, 09:59 PM
Walker NealPresident and CEODec 15, 2018 Option Exercise$7.318636,309908,032Dec 18, 2018, 08:54 PM
Ruffo FrankChief Financial OfficerDec 15, 2018 Option Exercise$7.313702,705161,515Dec 18, 2018, 08:54 PM
Shanler StuartChief Scientific OfficerDec 15, 2018 Option Exercise$7.313702,705268,442Dec 18, 2018, 08:53 PM
Ali-Jackson KamilChief Legal OfficerDec 15, 2018 Option Exercise$7.314933,60478,876Dec 18, 2018, 08:52 PM
Powala ChristopherChief Reg & Develop OfficerDec 15, 2018 Option Exercise$7.313572,610138,264Dec 18, 2018, 08:51 PM
Fair BrettChief Commercial OfficerDec 15, 2018 Option Exercise$7.312882,1056,763Dec 18, 2018, 08:51 PM
Mehra AnandDirectorOct 22, 2018 Buy$10.75372,0934,000,0001,911,573Oct 23, 2018, 07:13 PM
Tullman Stephen A.DirectorOct 04, 2018 Buy$14.007,10099,370177,457Oct 05, 2018, 04:37 PM
Tullman Stephen A.DirectorAug 23, 2018 Buy$15.006,60098,985170,357Aug 27, 2018, 04:46 PM
Tullman Stephen A.DirectorAug 15, 2018 Buy$15.976,25099,813163,757Aug 17, 2018, 04:55 PM
Ali-Jackson KamilChief Legal OfficerJun 12, 2018 Sale$20.004,90098,00077,636Jun 12, 2018, 06:42 PM
Ali-Jackson KamilChief Legal OfficerJun 11, 2018 Sale$20.001002,00082,536Jun 12, 2018, 06:42 PM
Ali-Jackson KamilChief Legal OfficerMay 18, 2018 Sale$20.0010,000200,00082,636May 21, 2018, 04:06 PM
Powell Andrew Kenneth WilliamDirectorMay 16, 2018 Buy$19.125009,560500May 17, 2018, 07:34 PM
Walker NealPresident and CEOMay 07, 2018 Option Exercise$18.103,45562,536905,862May 09, 2018, 04:22 PM
Shanler StuartChief Scientific OfficerMay 07, 2018 Option Exercise$18.101,48026,788267,512May 09, 2018, 04:21 PM
Ruffo FrankChief Financial OfficerMay 07, 2018 Option Exercise$18.101,48026,788160,585May 09, 2018, 04:20 PM
Powala ChristopherChief Reg & Develop OfficerMay 07, 2018 Option Exercise$18.101,48026,788137,321May 09, 2018, 04:19 PM
Fair BrettChief Commercial OfficerMay 07, 2018 Option Exercise$18.101,15320,8696,038May 09, 2018, 04:18 PM
Ali-Jackson KamilChief Legal OfficerMay 07, 2018 Option Exercise$18.101,97435,72992,636May 09, 2018, 04:17 PM
Ruffo FrankChief Financial OfficerMay 07, 2018 Buy$18.221,25022,775156,865May 07, 2018, 04:28 PM
Ruffo FrankChief Financial OfficerApr 06, 2018 Buy$16.591,25020,738155,615Apr 09, 2018, 04:51 PM
Tullman Stephen A.DirectorApr 06, 2018 Buy$16.5426,700441,618157,507Apr 09, 2018, 04:50 PM
Molineaux Christopher P.DirectorApr 06, 2018 Sale$16.522,30037,9967,682Apr 09, 2018, 04:50 PM
Walker NealPresident and CEOApr 05, 2018 Buy$16.7510,000167,500897,184Apr 09, 2018, 08:38 AM
Molineaux Christopher P.DirectorMar 20, 2018 Option Exercise$0.552,3771,3059,982Mar 22, 2018, 04:35 PM
Walker NealPresident and CEODec 18, 2017 Option Exercise$24.1288921,443878,166Dec 21, 2017, 04:58 PM
Walker NealPresident and CEODec 15, 2017 Option Exercise$24.2392222,340876,130Dec 21, 2017, 04:58 PM
Ruffo FrankChief Financial OfficerDec 18, 2017 Option Exercise$24.123809,166145,347Dec 21, 2017, 04:57 PM
Ruffo FrankChief Financial OfficerDec 15, 2017 Option Exercise$24.233959,571144,477Dec 21, 2017, 04:57 PM
Powala ChristopherChief Operating OfficerDec 18, 2017 Option Exercise$24.1249411,915133,601Dec 21, 2017, 04:57 PM
Powala ChristopherChief Operating OfficerDec 15, 2017 Option Exercise$24.233959,571132,470Dec 21, 2017, 04:57 PM
Ali-Jackson KamilChief Legal OfficerDec 18, 2017 Option Exercise$24.123277,88778,659Dec 21, 2017, 04:56 PM
Ali-Jackson KamilChief Legal OfficerDec 15, 2017 Option Exercise$24.2352712,76977,911Dec 21, 2017, 04:56 PM
Shanler StuartChief Scientific OfficerDec 18, 2017 Option Exercise$24.1244110,637263,792Dec 21, 2017, 04:55 PM
Shanler StuartChief Scientific OfficerDec 15, 2017 Option Exercise$24.233959,571262,783Dec 21, 2017, 04:55 PM
SCHIFF ANDREW NDirectorAug 16, 2017 Buy$23.02108,6012,499,995634,455Aug 16, 2017, 04:45 PM
Molineaux Christopher P.DirectorMar 17, 2017 Option Exercise$0.517,6053,8727,605Mar 21, 2017, 08:43 PM
VIVO VENTURES VII, LLC10% OwnerMar 02, 2017 Sale$31.202,66683,17960,972Mar 02, 2017, 08:44 PM
VIVO VENTURES VII, LLC10% OwnerMar 02, 2017 Sale$31.20122,3343,816,8212,797,597Mar 02, 2017, 08:44 PM
VIVO VENTURES VII, LLC10% OwnerMar 01, 2017 Sale$30.982,13366,08063,638Mar 02, 2017, 08:44 PM
VIVO VENTURES VII, LLC10% OwnerMar 01, 2017 Sale$30.9897,8673,031,9202,919,931Mar 02, 2017, 08:44 PM
VIVO VENTURES VII, LLC10% OwnerFeb 28, 2017 Sale$30.504,266130,11365,771Mar 02, 2017, 08:44 PM
VIVO VENTURES VII, LLC10% OwnerFeb 28, 2017 Sale$30.50195,7345,969,8873,017,798Mar 02, 2017, 08:44 PM
Mehra AnandDirectorJan 10, 2017 Sale$28.25750,00021,188,3251,539,480Jan 12, 2017, 05:50 PM
Powala ChristopherChief Operating OfficerDec 18, 2016 Option Exercise$31.2549415,438131,565Dec 20, 2016, 06:51 PM
Ruffo FrankChief Financial OfficerDec 18, 2016 Option Exercise$31.2538011,875143,572Dec 20, 2016, 06:51 PM
Ali-Jackson KamilChief Legal OfficerDec 18, 2016 Option Exercise$31.2532710,21976,705Dec 20, 2016, 06:50 PM
Walker NealPresident and CEODec 18, 2016 Option Exercise$31.2588927,781874,019Dec 20, 2016, 06:49 PM
Shanler StuartChief Scientific OfficerDec 18, 2016 Option Exercise$31.2544113,781261,878Dec 20, 2016, 06:49 PM
VIVO VENTURES VII, LLC10% OwnerNov 18, 2016 Sale$22.72440,40210,005,9333,213,532Nov 18, 2016, 07:44 PM
VIVO VENTURES VII, LLC10% OwnerNov 16, 2016 Sale$27.309,765266,58479,635Nov 18, 2016, 07:44 PM
VIVO VENTURES VII, LLC10% OwnerNov 16, 2016 Sale$23.25448,06310,417,4653,653,934Nov 18, 2016, 07:44 PM
VIVO VENTURES VII, LLC10% OwnerNov 18, 2016 Sale$22.729,598218,06770,037Nov 18, 2016, 07:44 PM
Ali-Jackson KamilChief Legal OfficerOct 26, 2016 Option Exercise$1.523,9125,94679,869Oct 28, 2016, 04:10 PM
Ali-Jackson KamilChief Legal OfficerOct 26, 2016 Sale$21.833,91285,39975,957Oct 28, 2016, 04:10 PM
FMR LLC10% OwnerOct 26, 2016 Sale$21.943,75082,2602,571,454Oct 28, 2016, 03:39 PM
Ali-Jackson KamilChief Legal OfficerSep 28, 2016 Option Exercise$0.721,8411,32677,798Sep 28, 2016, 06:10 PM
Ali-Jackson KamilChief Legal OfficerSep 28, 2016 Sale$24.661,84145,39975,957Sep 28, 2016, 06:10 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerSep 16, 2016 Sale$24.51173,6004,254,2122,125,769Sep 19, 2016, 05:15 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerSep 15, 2016 Sale$24.04351,9508,459,2902,607,719Sep 19, 2016, 05:15 PM
Ali-Jackson KamilChief Legal OfficerAug 26, 2016 Sale$20.353,73876,06820,289Aug 29, 2016, 04:15 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerFeb 23, 2016 Buy$17.6228,408500,5122,627,719Feb 24, 2016, 04:56 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerFeb 22, 2016 Buy$15.9911,318180,9582,599,311Feb 24, 2016, 04:56 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerJan 20, 2016 Buy$19.881,80335,8492,587,993Jan 20, 2016, 04:51 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerJan 19, 2016 Buy$19.884,20083,4802,586,190Jan 20, 2016, 04:51 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerJan 15, 2016 Buy$19.861,80035,7432,581,990Jan 20, 2016, 04:51 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerJan 13, 2016 Buy$19.975,543110,6742,580,190Jan 13, 2016, 04:39 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerJan 12, 2016 Buy$19.125,941113,5852,574,647Jan 13, 2016, 04:39 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerJan 11, 2016 Buy$17.934,15374,4792,568,706Jan 13, 2016, 04:39 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerOct 29, 2015 Buy$14.0095,0001,330,0002,564,552Oct 30, 2015, 03:53 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerOct 28, 2015 Buy$14.00149,2002,088,8002,469,552Oct 30, 2015, 03:53 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerOct 22, 2015 Buy$14.035,41075,8832,320,352Oct 26, 2015, 04:17 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerOct 21, 2015 Buy$14.833,10045,9762,314,942Oct 21, 2015, 04:35 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerOct 20, 2015 Buy$14.957,965119,0702,311,842Oct 21, 2015, 04:35 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerOct 19, 2015 Buy$14.8823,934356,0492,303,877Oct 21, 2015, 04:35 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerOct 14, 2015 Buy$14.0642,813601,7922,279,943Oct 16, 2015, 04:17 PM
FMR LLC10% OwnerOct 13, 2015 Buy$11.00335,4553,690,0053,804,279Oct 14, 2015, 02:40 PM
CHA ALBERTDirectorOct 13, 2015 Buy$11.00454,5454,999,9954,191,397Oct 13, 2015, 01:30 PM
VIVO VENTURES VII, LLC10% OwnerOct 13, 2015 Buy$11.009,695106,64589,400Oct 13, 2015, 01:29 PM
VIVO VENTURES VII, LLC10% OwnerOct 13, 2015 Buy$11.00444,8504,893,3504,101,997Oct 13, 2015, 01:29 PM
Mehra AnandDirectorOct 13, 2015 Buy$11.00409,0904,499,9902,289,480Oct 13, 2015, 01:26 PM
Sofinnova Venture Partners VIII, L.P.10% OwnerOct 13, 2015 Buy$11.00409,0904,499,9902,289,480Oct 13, 2015, 01:26 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerOct 08, 2015 Buy$11.0021,691238,5552,237,130Oct 13, 2015, 09:34 AM
RA CAPITAL MANAGEMENT, LLC10% OwnerOct 07, 2015 Buy$10.862,215,43924,051,3642,215,439Oct 13, 2015, 09:34 AM
VIVO VENTURES VII, LLC10% OwnerOct 07, 2015 Buy$11.002853,1356,467Oct 09, 2015, 04:05 PM
VIVO VENTURES VII, LLC10% OwnerOct 07, 2015 Buy$11.0013,067143,737296,739Oct 09, 2015, 04:05 PM
CHA ALBERTDirectorOct 07, 2015 Buy$11.0013,352146,872303,206Oct 09, 2015, 04:03 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Walker NealInterim President and CEO03/01/20243,997
Monahan JosephChief Scientific Officer03/02/20244,378
Monahan JosephChief Scientific Officer03/01/202422,012
Balthaser KevinChief Financial Officer03/02/2024529
Balthaser KevinChief Financial Officer03/01/20241,228
Monahan JosephChief Scientific Officer02/01/20243,100
Loerop JamesChief Business Officer02/01/20247,705
Manion Douglas J.Pres and CEO01/01/20249,581
Monahan JosephChief Scientific Officer10/23/202330,460
Balthaser KevinChief Financial Officer09/06/202374,971
Balthaser KevinChief Financial Officer09/01/20232,252
Loerop JamesChief Business Officer08/28/202399,959
Monahan JosephChief Scientific Officer08/21/202343,895
Manion Douglas J.Pres and CEO08/01/202343,527
Molineaux Christopher P.Director06/20/202323,265
Monahan JosephChief Scientific Officer06/20/202361,663
Molineaux Christopher P.Director06/15/2023338
Manion Douglas J.Pres and CEO03/17/202349,532
Manion Douglas J.Pres and CEO03/09/202350,278
Walker NealDirector03/03/2023382,070
Walker NealDirector03/02/2023358,588
Monahan JosephChief Scientific Officer03/03/2023202,615
Monahan JosephChief Scientific Officer03/02/2023183,024
Balthaser KevinChief Financial Officer03/03/202311,290
Balthaser KevinChief Financial Officer03/02/202312,289
Monahan JosephChief Scientific Officer02/15/202365,311
Loerop JamesChief Business Officer02/08/202359,272
Walker NealDirector02/02/202381,248
Walker NealDirector02/01/2023418,675
Walker NealDirector01/04/2023223,342
Walker NealDirector01/03/2023381,213
Monahan JosephChief Scientific Officer12/15/202279,412
SCHIFF ANDREW NDirector11/14/202223,417
SCHIFF ANDREW NDirector11/11/2022702,177
SCHIFF ANDREW NDirector11/10/2022193,995
SCHIFF ANDREW NDirector10/26/2022247,253
SCHIFF ANDREW NDirector10/25/2022204,516
SCHIFF ANDREW NDirector10/24/2022248,586
SCHIFF ANDREW NDirector10/17/2022320,087
SCHIFF ANDREW NDirector10/18/2022542,022
Monahan JosephChief Scientific Officer10/17/202279,907
SCHIFF ANDREW NDirector10/07/2022118,349
SCHIFF ANDREW NDirector10/06/2022625,744
SCHIFF ANDREW NDirector10/04/2022123,259
SCHIFF ANDREW NDirector06/17/2022296,269
Walker NealPresident and CEO04/25/2022303,656
Walker NealPresident and CEO04/22/2022376,097
Walker NealPresident and CEO04/21/2022380,947
Monahan JosephChief Scientific Officer04/18/2022488,298
Walker NealPresident and CEO03/11/2022896,045
Ruffo FrankChief Financial Officer03/10/2022199,335
Monahan JosephChief Scientific Officer03/10/2022426,803
Monahan JosephChief Scientific Officer02/09/20224,857
Ruffo FrankChief Financial Officer02/09/202217,568
Walker NealPresident and CEO02/09/202245,513
Monahan JosephChief Scientific Officer09/01/202117,926
Gordon David N.Chief Medical Officer07/13/202144,675
Ali-Jackson KamilChief Legal Officer06/03/2021208,421
Gordon David N.Chief Medical Officer06/02/2021820,209
Gordon David N.Chief Medical Officer06/01/2021322,165
Ali-Jackson KamilChief Legal Officer06/02/2021651,664
Ali-Jackson KamilChief Legal Officer06/01/2021345,299
Monahan JosephChief Scientific Officer06/02/2021471,437
Ruffo FrankChief Financial Officer06/02/2021325,383
Walker NealPresident and CEO06/02/2021719,735
Ruffo FrankChief Financial Officer04/26/2021705,228
Ruffo FrankChief Financial Officer04/23/2021799,660
Ruffo FrankChief Financial Officer04/22/2021805,218
Walker NealPresident and CEO04/22/2021805,239
Gordon David N.Chief Medical Officer03/02/202153,010
Gordon David N.Chief Medical Officer03/01/2021136,180
Ali-Jackson KamilChief Legal Officer03/02/202144,315
Ali-Jackson KamilChief Legal Officer03/01/2021118,712
Ruffo FrankChief Financial Officer03/02/202166,123
Ruffo FrankChief Financial Officer03/01/2021176,432
Walker NealPresident and CEO03/02/2021185,582
Walker NealPresident and CEO03/01/2021957,395
Mehra AnandDirector02/02/2021268,298
Ruffo FrankChief Financial Officer02/01/202127,926
Ali-Jackson KamilChief Legal Officer02/01/202128,139
Walker NealPresident and CEO02/01/202170,797
Walker NealPresident and CEO12/15/20203,998
Ruffo FrankChief Financial Officer12/15/20201,698
Ali-Jackson KamilChief Legal Officer12/15/20202,286
Walker NealPresident and CEO09/01/202055,622
Gordon David N.Chief Medical Officer07/02/20202,040
Walker NealPresident and CEO06/01/202027,688
Ruffo FrankChief Financial Officer06/01/202012,475
Gordon David N.Chief Medical Officer06/01/202031,739
Ali-Jackson KamilChief Legal Officer06/01/202012,585
Walker NealPresident and CEO03/02/202053,832
Ruffo FrankChief Financial Officer03/02/20209,024
Ali-Jackson KamilChief Legal Officer03/02/20206,022
Gordon David N.Chief Medical Officer03/02/20206,945
Walker NealPresident and CEO02/03/20204,704
Ruffo FrankChief Financial Officer02/03/20201,674
Ali-Jackson KamilChief Legal Officer02/03/20201,687
Walker NealPresident and CEO12/18/20191,345
Ruffo FrankChief Financial Officer12/18/2019644
Ali-Jackson KamilChief Legal Officer12/18/2019501
Walker NealPresident and CEO12/16/20191,408
Ruffo FrankChief Financial Officer12/16/2019666
Ali-Jackson KamilChief Legal Officer12/16/2019895
Gordon David N.Chief Medical Officer07/02/20193,856
Flynn James E10% Owner06/27/20191,589,668
Flynn James E10% Owner06/27/2019292,409
Flynn James E10% Owner06/26/20196,086
Flynn James E10% Owner06/26/20191,585
Flynn James E10% Owner06/24/2019226,925
Flynn James E10% Owner06/24/201959,077
Flynn James E10% Owner06/21/20191,243,398
Flynn James E10% Owner06/21/2019323,701
Flynn James E10% Owner06/25/2019184,189
Flynn James E10% Owner06/25/201947,948
Flynn James E10% Owner05/09/20191,064,016
Flynn James E10% Owner05/09/20191,609,232
Flynn James E10% Owner05/10/2019434,750
Flynn James E10% Owner05/10/2019657,524
Walker NealPresident and CEO02/01/201924,910
Powala ChristopherChief Reg & Develop Officer02/01/20197,753
Shanler StuartChief Scientific Officer02/01/20199,104
Ruffo FrankChief Financial Officer02/01/20199,104
Fair BrettChief Commercial Officer02/01/20199,104
Ali-Jackson KamilChief Legal Officer02/01/20199,104
Ruffo FrankChief Financial Officer12/18/20182,243
Walker NealPresident and CEO12/18/20185,248
Shanler StuartChief Scientific Officer12/18/20182,596
Fair BrettChief Commercial Officer12/18/20183,137
Powala ChristopherChief Reg & Develop Officer12/18/20182,810
Ali-Jackson KamilChief Legal Officer12/18/20181,928
Walker NealPresident and CEO12/15/20186,309
Ruffo FrankChief Financial Officer12/15/20182,705
Shanler StuartChief Scientific Officer12/15/20182,705
Ali-Jackson KamilChief Legal Officer12/15/20183,604
Powala ChristopherChief Reg & Develop Officer12/15/20182,610
Fair BrettChief Commercial Officer12/15/20182,105
Mehra AnandDirector10/22/20184,000,000
Tullman Stephen A.Director10/04/201899,370
Tullman Stephen A.Director08/23/201898,985
Tullman Stephen A.Director08/15/201899,813
Ali-Jackson KamilChief Legal Officer06/12/201898,000
Ali-Jackson KamilChief Legal Officer06/11/20182,000
Ali-Jackson KamilChief Legal Officer05/18/2018200,000
Powell Andrew Kenneth WilliamDirector05/16/20189,560
Walker NealPresident and CEO05/07/201862,536
Shanler StuartChief Scientific Officer05/07/201826,788
Ruffo FrankChief Financial Officer05/07/201826,788
Powala ChristopherChief Reg & Develop Officer05/07/201826,788
Fair BrettChief Commercial Officer05/07/201820,869
Ali-Jackson KamilChief Legal Officer05/07/201835,729
Ruffo FrankChief Financial Officer05/07/201822,775
Ruffo FrankChief Financial Officer04/06/201820,738
Tullman Stephen A.Director04/06/2018441,618
Molineaux Christopher P.Director04/06/201837,996
Walker NealPresident and CEO04/05/2018167,500
Molineaux Christopher P.Director03/20/20181,305
Walker NealPresident and CEO12/18/201721,443
Walker NealPresident and CEO12/15/201722,340
Ruffo FrankChief Financial Officer12/18/20179,166
Ruffo FrankChief Financial Officer12/15/20179,571
Powala ChristopherChief Operating Officer12/18/201711,915
Powala ChristopherChief Operating Officer12/15/20179,571
Ali-Jackson KamilChief Legal Officer12/18/20177,887
Ali-Jackson KamilChief Legal Officer12/15/201712,769
Shanler StuartChief Scientific Officer12/18/201710,637
Shanler StuartChief Scientific Officer12/15/20179,571
SCHIFF ANDREW NDirector08/16/20172,499,995
Molineaux Christopher P.Director03/17/20173,872
VIVO VENTURES VII, LLC10% Owner03/02/201783,179
VIVO VENTURES VII, LLC10% Owner03/02/20173,816,821
VIVO VENTURES VII, LLC10% Owner03/01/201766,080
VIVO VENTURES VII, LLC10% Owner03/01/20173,031,920
VIVO VENTURES VII, LLC10% Owner02/28/2017130,113
VIVO VENTURES VII, LLC10% Owner02/28/20175,969,887
Mehra AnandDirector01/10/201721,188,325
Powala ChristopherChief Operating Officer12/18/201615,438
Ruffo FrankChief Financial Officer12/18/201611,875
Ali-Jackson KamilChief Legal Officer12/18/201610,219
Walker NealPresident and CEO12/18/201627,781
Shanler StuartChief Scientific Officer12/18/201613,781
VIVO VENTURES VII, LLC10% Owner11/18/201610,005,933
VIVO VENTURES VII, LLC10% Owner11/16/2016266,584
VIVO VENTURES VII, LLC10% Owner11/16/201610,417,465
VIVO VENTURES VII, LLC10% Owner11/18/2016218,067
Ali-Jackson KamilChief Legal Officer10/26/20165,946
Ali-Jackson KamilChief Legal Officer10/26/201685,399
FMR LLC10% Owner10/26/201682,260
Ali-Jackson KamilChief Legal Officer09/28/20161,326
Ali-Jackson KamilChief Legal Officer09/28/201645,399
RA CAPITAL MANAGEMENT, LLC10% Owner09/16/20164,254,212
RA CAPITAL MANAGEMENT, LLC10% Owner09/15/20168,459,290
Ali-Jackson KamilChief Legal Officer08/26/201676,068
RA CAPITAL MANAGEMENT, LLC10% Owner02/23/2016500,512
RA CAPITAL MANAGEMENT, LLC10% Owner02/22/2016180,958
RA CAPITAL MANAGEMENT, LLC10% Owner01/20/201635,849
RA CAPITAL MANAGEMENT, LLC10% Owner01/19/201683,480
RA CAPITAL MANAGEMENT, LLC10% Owner01/15/201635,743
RA CAPITAL MANAGEMENT, LLC10% Owner01/13/2016110,674
RA CAPITAL MANAGEMENT, LLC10% Owner01/12/2016113,585
RA CAPITAL MANAGEMENT, LLC10% Owner01/11/201674,479
RA CAPITAL MANAGEMENT, LLC10% Owner10/29/20151,330,000
RA CAPITAL MANAGEMENT, LLC10% Owner10/28/20152,088,800
RA CAPITAL MANAGEMENT, LLC10% Owner10/22/201575,883
RA CAPITAL MANAGEMENT, LLC10% Owner10/21/201545,976
RA CAPITAL MANAGEMENT, LLC10% Owner10/20/2015119,070
RA CAPITAL MANAGEMENT, LLC10% Owner10/19/2015356,049
RA CAPITAL MANAGEMENT, LLC10% Owner10/14/2015601,792
FMR LLC10% Owner10/13/20153,690,005
CHA ALBERTDirector10/13/20154,999,995
VIVO VENTURES VII, LLC10% Owner10/13/2015106,645
VIVO VENTURES VII, LLC10% Owner10/13/20154,893,350
Mehra AnandDirector10/13/20154,499,990
Sofinnova Venture Partners VIII, L.P.10% Owner10/13/20154,499,990
RA CAPITAL MANAGEMENT, LLC10% Owner10/08/2015238,555
RA CAPITAL MANAGEMENT, LLC10% Owner10/07/201524,051,364
VIVO VENTURES VII, LLC10% Owner10/07/20153,135
VIVO VENTURES VII, LLC10% Owner10/07/2015143,737
CHA ALBERTDirector10/07/2015146,872
Load More Insider Transactions
FUNDS WITH A POSITION IN ACLARIS THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.5,905,8720.00016%5.31%Other
RA CAPITAL MANAGEMENT, L.P.00.00000%-100.00%Other
D. E. SHAW & CO., INC.1,939,0100.00178%2837.45%Other
RENAISSANCE TECHNOLOGIES LLC1,746,4320.00284%169.66%Other
GEODE CAPITAL MANAGEMENT, LLC1,393,5480.00015%4.22%Other
BLACKSTONE INC.13,0330.00006%-98.97%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.1,000,0000.02%ExitedOther
VIVO CAPITAL, LLC898,6310.67%ExitedOther
UBS OCONNOR LLC70,000 (Call)0.00219%ExitedValue
UBS OCONNOR LLC68,0140.00873%ExitedValue
ALPS ADVISORS INC52,2220.00297%ExitedOther
TUDOR INVESTMENT CORP ET AL33,1830.00028%No changeEvent Driven, Other
BALYASNY ASSET MANAGEMENT L.P.10,5110.00015%ExitedEvent Driven
CHANGE IN SHARES OUTSTANDING FOR ACLARIS THERAPEUTICS INC
STOCK BUYBACKS FOR ACLARIS THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.10%
1Q
12/31/2023
06/30/2023
0.35%
2Q
12/31/2023
03/31/2023
5.99%
3Q
12/31/2023
12/31/2022
6.26%
4Q
12/31/2023
09/30/2022
6.30%
5Q
12/31/2023
06/30/2022
7.41%
6Q
12/31/2023
03/31/2022
15.38%
7Q
12/31/2023
12/31/2021
15.67%
8Q
12/31/2023
09/30/2021
15.78%
9Q
12/31/2023
06/30/2021
31.33%
10Q
12/31/2023
03/31/2021
40.80%
11Q
12/31/2023
12/31/2020
62.58%
12Q
12/31/2023
09/30/2020
65.59%
13Q
12/31/2023
06/30/2020
68.22%
14Q
12/31/2023
03/31/2020
70.30%
15Q
12/31/2023
12/31/2019
71.18%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.10%
1Q
06/30/2023
0.35%
2Q
03/31/2023
5.99%
3Q
12/31/2022
6.26%
4Q
09/30/2022
6.30%
5Q
06/30/2022
7.41%
6Q
03/31/2022
15.38%
7Q
12/31/2021
15.67%
8Q
09/30/2021
15.78%
9Q
06/30/2021
31.33%
10Q
03/31/2021
40.80%
11Q
12/31/2020
62.58%
12Q
09/30/2020
65.59%
13Q
06/30/2020
68.22%
14Q
03/31/2020
70.30%
15Q
12/31/2019
71.18%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ACLARIS THERAPEUTICS INC
LOADING...